2023
DOI: 10.1016/j.rvsc.2023.01.007
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacokinetic profiles of the two major active metabolites of metamizole, 4-methylaminoantipyrine (MAA) and 4-aminoantipyrine (AA), after intravenous injection in cats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 25 publications
0
0
0
Order By: Relevance
“…The crude products were further purified by washing with diethyl ether. Finally, to prepare compound (6), 1 mmol of compound (5) was taken in THF (20 ml), and 1.5 mmol of Grignard reagent was added at 0ºC. After the reaction was complete, the mixture was allowed to reach room temperature.…”
Section: Accepted Manuscriptmentioning
confidence: 99%
See 1 more Smart Citation
“…The crude products were further purified by washing with diethyl ether. Finally, to prepare compound (6), 1 mmol of compound (5) was taken in THF (20 ml), and 1.5 mmol of Grignard reagent was added at 0ºC. After the reaction was complete, the mixture was allowed to reach room temperature.…”
Section: Accepted Manuscriptmentioning
confidence: 99%
“…It is recommended to take dichloralphenazone to treat tension and vascular headaches [5]. Metamizole has been effectively employed for perioperative pain, cancerrelated pain, acute injuries, and various other types of pain, being considered one of the most potent antipyretic agents [6]. Furthermore, several investigational small molecules containing the pyrazolone structure are under consideration as potential drug candidates, including sulfamazone [7], propyphenazone [8], and nifenazone [9].…”
Section: Introductionmentioning
confidence: 99%